CytoDyn (CYDY)
OTHER OTC:CYDY
Holding CYDY?
Track your performance easily

CytoDyn (CYDY) Stock Price & Analysis

634 Followers

CYDY Stock Chart & Stats


Financials

Annual

Ownership Overview

6.56%0.02%0.02%93.41%
6.56%
Insiders
0.02% Other Institutional Investors
93.41% Public Companies and
Individual Investors

Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

CYDY FAQ

What was CytoDyn’s price range in the past 12 months?
CytoDyn lowest stock price was $0.11 and its highest was $0.42 in the past 12 months.
    What is CytoDyn’s market cap?
    Currently, no data Available
    When is CytoDyn’s upcoming earnings report date?
    The company’s upcoming earnings report date is not yet available.
    How were CytoDyn’s earnings last quarter?
    Currently, no data Available
    Is CytoDyn overvalued?
    According to Wall Street analysts CytoDyn’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
      Does CytoDyn pay dividends?
      CytoDyn does not currently pay dividends.
      What is CytoDyn’s EPS estimate?
      CytoDyn’s EPS estimate for its next earnings report is not yet available.
      How many shares outstanding does CytoDyn have?
      CytoDyn has 1,219,841,900 shares outstanding.
        What happened to CytoDyn’s price movement after its last earnings report?
        Currently, no data Available
        Which hedge fund is a major shareholder of CytoDyn?
        Currently, no hedge funds are holding shares in CYDY
        ---

        CytoDyn Stock Smart Score

        10
        Unlock Smart Score
        1
        2
        3
        4
        5
        6
        7
        8
        9
        10

        Company Description

        CytoDyn

        CytoDyn, Inc. is a clinical-stage biotechnology company, which engages in the development of innovative treatments for multiple therapeutic indications based on leronlimab. Its product include HIV, cancer, graft-versus-host disease (GVHD), and PCa test. The company was founded by Allen D. Allen on May 2, 2002 and is headquartered in Vancouver, WA.
        ---
        Similar Stocks
        Company
        Price & Change
        Follow
        Ovid Therapeutics
        Tonix Pharma
        Atea Pharmaceuticals
        Kura Oncology
        Popular Stocks
        ---
        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis